Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
RDY: Dr. Reddy's Laboratories Limited Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
RDY
The Story
RDY
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+16.6% / yr
Operating margin
10.6%
ROIC
5.8%
Financially safe
Strong
Debt / equity
0.24×
Interest coverage
8.5×
Current ratio
1.80×
Valuation
Unrated
P/E ratio
28.9×
Dividend yield
0.7%
Dr. Reddy's Laboratories Limited
RDY
New York Stock Exchange
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Dr. Reddy's Laboratories Limited
RDY
New York Stock Exchange
·
USD
·
Closed
$11.85
+0.17%
$11.85
+$0.02 (0.17%)
52W Range
11th
pctl
Volume
0.98×
avg
Mkt Cap
9.87B
USD
P/E
28.9
TTM
Div Yield
0.70%
ann
52W Range
11th
pctl
Volume
0.98×
avg
Market Cap
9.87B
USD
P/E Ratio
28.9
TTM
Div Yield
0.70%
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings